ITOH Kyogo 伊東恭悟

… Alternative Names

伊東恭悟イトウキヨウゴ

伊藤恭悟イトウキョウゴ

Less

Researcher Number	50125499
Affiliation (Current)	2023: 久留米大学, 付置研究所, 教授
Affiliation (based on the past Project Information) *help	2015 – 2021: 久留米大学, 付置研究所, 教授 2016: 久留米大学, 医学部, 教授 1993 – 2009: 久留米大学, 医学部, 教授 1995: 久留米大学, 医学部・免疫, 教授
Review Section/Research Field	Principal Investigator Digestive surgery / Biological Sciences / Living organism molecular science Except Principal Investigator Digestive surgery / Thoracic surgery / Biological Sciences / General surgery / Basic Section 56030:Urology-related / Urology / Dermatology / Gastroenterology
Keywords	Principal Investigator キラーT細胞 / 癌退縮抗原 / 抗原ペプチド / 扁平上皮癌 / 遺伝子 / 消化器癌 / 癌ワクチン / 上皮性癌 / HLA-A2601拘束性 / 遺伝子クローニング … More / immunology / biotechnology / allergy / virus / cancer / 免疫学 / バイオテクノロジー / 癌 / ウィルス / アレルギー・ぜんそく / Personalized medicine / Translational reearch / Vaccine / Cytotoxic T lymphocytes / Immunity / Peptide / Tumor antigen / Gene / 免疫療法 / アポトーシス / 抗原 / がん / NK細胞 / 拒絶抗原 / テーラーメイド型医療 / 探索的臨床研究 / ワクチン / 免疫 / ペプチド / 癌抗原 / Peptide antigen / SART1 / HLA-class I / cancer vaccine / gene cloning / tumor-rejection antigen / cancer of digestive tract / HLA-クラスI / ペプチド抗原 / SART-1 / HLA-クラス1 / tumor-infiltrating lymphocytes / cytotoxic Tlymphocytes / Cancer of digestive tract / Serum MAGE-4 protein / Lung Cancer / Cancer Vaccine / Tumor-rejection antigen / MAGE gene / ペプチドワクチン / HLA-class I拘束性 / MAGE / 癌浸潤リンパ球 / 血中MAGE蛋白 / 肺癌 / 腫瘍退縮抗原 / MAGE遺伝子 / 単クローン抗体 / テーラーメイドペプチドワクチン / バイオマーカー / ペプチド抗体 / がん治療ペプチドワクチン / SART-1遺伝子 / HLA-A2 / HLA-A24 / 癌ペプチドワクチン / ペプチド分子 / 癌特異免疫療法 / キラーT細胞(CTL) / 癌拒絶抗原遺伝子 / HLA-クラスI拘束性 / がん退縮抗原遺伝子 / T細胞抗原レセプター / がん抗原 / TCR usage / 癌抗原ペプチド / cDNAクローニング / MAGE遺伝子ファミリー / ヒト癌退縮抗原遺伝子 / ヒト癌特異免疫 / T細胞抗原レセプター遺伝子 … More Except Principal Investigator 癌退縮抗原 / 癌ワクチン / MAGE gene family / 癌拒絶抗原 / CTL / 尿路上皮がん / がんペプチドワクチン / AHNAK / Two-hybrid / HLA-A24 / 遺伝子 / tumor rejection antigen / 肺癌 / 特異的CTL / 特異的免疫療法 / MAGE gene / キラーT細胞 / 大腸癌 / MAGE遺伝子 / 食道癌 / HLA拘束性 / ELISA / モノクローナル抗体 / T細胞レセプター / クラスIb / 癌遺伝子 / 癌抗原ペプチド / 腫瘍免疫 / トリプルネガティブ乳がん / 乳がん / トリプルネガティブ乳癌 / ペプチドワクチン / 個別化治療 / 尿路がん / がんワクチン / 複合療法 / 複合免疫療法 / がん免疫療法 / 生存率 / サイトカイン / バイオマーカー / immunotherapy / peptide vaccine / colorectal cancer / 臨床第1相臨床試験 / ペプチド / 癌免疫療法 / 再発進行大腸癌 / 特異的癌免疫療法 / molecular biclogy / Cell adhesion / BS cell / Keratinocyte / Desincykin / Knockoit mouse / Desmosome / エンボプラキン / デスモグレイン / デスモヨーキンケラチノサイト / 細胞膜 / 核移行 / デスモソーム / 癌抑制遺伝子 / ノックアウトマウス / デスモヨーキン / 細胞内情報伝達 / 細胞接着 / ケラチノサイト / 表皮 / homeostasis / chromosome / immune system / multistep carcinogenesis / environmental factors / gene / oncogenesis / cancer / 細胞 / 環境 / 染色体 / 発生工学 / 免疫 / 家系 / 多段階発がん / 環境要因 / がん / Apoptosis / Cell cycle / DNA-binding protein / Tumor rejection antigen / ファー・ウェスタン / ロイシン・ジッパー・モチーフ / 核内蛋白 / SART 1 / ゲノムDNA / 遺伝子ファミリー / ファーウエスタン / アポトーシス / 細胞周期 / DNA結合蛋白 / Specific immunotherapy / Peptide antigen / HLA-class I / Cancer Vaccine / Gene / Tumor-rejection / Lung cancer / 特異免疫療法 / ペプチド抗原 / HLA-クラスI / HLA restriction / gene cloning / 願拒絶抗原 / 遺伝子クローニング / cancer vaccine / CTLs / Lung Cancer / 抗体 / 血清 / MAGE癌退縮抗原遺伝子 / HLA-A2601拘束性 / 癌退縮抗原遺伝子 / killer T cell / lymphocytes / polyclonal antibody / monoclonal antibody / MAGE-4 protein / MAGE-1 protein / MAGE-1遺伝子 / 腫瘍マーカー / killer T細胞 / HLA class I抗原 / MAGE蛋白抗原 / リンパ球 / ポリクローナル抗体 / MAGE-4蛋白 / MAGE-1蛋白 / cytotoxic T lymphocytes / serum MAGE antigen / Gene expression / Solid tumor / Colon cancer / Tumor-rejection antigen / 血中抗体 / 血中MAGE抗原 / MAGE遺伝子ファミリー / 遺伝子発現 / 固形癌 / 新しい物療法 / トランスレーショナルリサーチ / 分子創薬 / トランスレーショナル・リサーチ / 新しい物理療法 / ドラッグデリバリーシステム / 分子標的治療 / 分子標的 / HLA-A2402 / 扁平上皮癌 / bicistronic gene / 細胞周期依存性 / ロイシンジッパー・モチーフ / gene-expression cloning法 / (SART-1) / 抗原ペプチド / cytotoxic T-cell(CTL) / 卵巣癌 / 癌 / 腫瘍 / 癌免疫 / アルコール性肝疾患 / B型肝炎ウイルス関連肝硬変 / B型肝炎ウイルス関連肝癌 / C型肝炎ウイルス関連肝硬変 / C型肝炎ウイルス関連肝癌 / 血清中MAGE-4抗原 / アンチセンスDNA・RNA / 画像診断 / 養子免疫療法 / バイスペシフィック抗体 / イディオタイプネットワーク / 主要組織適合抗原複合体結合ペプチド / 細胞傷害性T細胞 / 癌抗原提示分子 / HLA Less

Next generation personalized peptide vaccination for advanced urothelial carcinoma patients
- Principal Investigator
  
  Suekane Shigetaka
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kurume University
Biomarkers of personalized peptide vaccination for metastatic upper tract urothelial carcinoma
- Principal Investigator
  
  Suekane Shigetaka
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kurume University
The Development of Peptide Vaccines for Triple Negative Breast Cancer Treatment
- Principal Investigator
  
  Toh Uhi
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Kurume University
Study of molecular basis for T cell-mediated recognition of antigens in subjects with HLA-A3 super typePrincipal Investigator
- Principal Investigator
  
  ITOH Kyogo
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Living organism molecular science
- Research Institution
  Kurume University
Basic research of peptide vaccine as therapeutic cancer vaccinePrincipal Investigator
- Principal Investigator
  
  ITOH Kyogo
- Project Period (FY)
  2005 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Kurume University
New therapeutic strategies for treatment of cancer based on basic research
- Principal Investigator
  
  UEDA Ryuzo
- Project Period (FY)
  2004 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Nagoya City University
Basic and clinical studies for development of peptide vaccine for colorectal cancer
- Principal Investigator
  
  SASATOMI Teruo md
- Project Period (FY)
  2001 – 2003
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Kurume University
Study of tumor associated antigens recognized by human CD8^+ cytotoxic T lymphocytesPrincipal Investigator
- Principal Investigator
  
  ITOH Kyogo
- Project Period (FY)
  2000 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Kurume University School of Medicine
Mechanisms of oncogenesis and anti-oncogenesis
- Principal Investigator
  
  SASAZUKI Takehiko
- Project Period (FY)
  1999 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  International Medical Center of Japan
  Kyushu University
Development of knockout mouse of desmoyokin(AHNAK)and analysis of its functio
- Principal Investigator
  
  MORI Osamu
- Project Period (FY)
  1999 – 2001
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Dermatology
- Research Institution
  Kurume University School of Medicine(Department of Dermatology)
新規HLA-A2402拘束性扁平上皮癌拒絶抗原(SART-2)の解析
- Principal Investigator
  
  中尾真修
- Project Period (FY)
  1998
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (A)
- Research Institution
  Kurume University
The Biological Functions of the SART-1 Family in Differentiation and Carcinogenicity of Adenocarcinomas
- Principal Investigator
  
  SHICHIJO Shigeki
- Project Period (FY)
  1998 – 1999
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
ヒト癌退縮抗原 SART-1 分子の解析
- Principal Investigator
  
  七條茂樹
- Project Period (FY)
  1997
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Kurume University
Identification of genes encoding tumor-rejection antigens of cancers from digestive tract and development of cancer vaccinePrincipal Investigator
- Principal Investigator
  
  ITOH Kyogo
- Project Period (FY)
  1997 – 1998
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Digestive surgery
- Research Institution
  Kurume University School of Medicine
Cloning of the HLA A2402 restricted rejection antigen gene in colorectal cancers
- Principal Investigator
  
  SASATOMI Teruo
- Project Period (FY)
  1997 – 1998
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Kurume University
Detection of tumor-rejection antigens of lung cancer and development of lung cancer vaccines.
- Principal Investigator
  
  HAYASHI Akihiko
- Project Period (FY)
  1997 – 1999
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Thoracic surgery
- Research Institution
  Kurume University
ヒト自家癌腫瘍に対するCLT株作製に基づく腫瘍特異免疫療法Principal Investigator
- Principal Investigator
  
  伊東恭悟
- Project Period (FY)
  1996 – 1999
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (A)
- Research Institution
  Kurume University
C型肝炎陽性者における肝癌予測因子としての血中MAGE癌退縮抗原の測定
- Principal Investigator
  
  七條茂樹
- Project Period (FY)
  1996
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Kurume University
HLA-A2拘束性卵巣癌特異的癌退縮抗原遺伝子のクローニング
- Principal Investigator
  
  山田亮
- Project Period (FY)
  1996
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Kurume University
ヒト自家癌拒絶の免疫学的分子機構
- Principal Investigator
  
  菊地浩吉
- Project Period (FY)
  1995
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Sapporo Medical University
抗原分子を基盤とした癌免疫療法の基礎的研究
- Principal Investigator
  
  高橋利忠
- Project Period (FY)
  1995
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Aichi Cancer Center Research Institute
HLA-A26拘束性扁平上皮癌特異的癌退縮抗原遺伝子の同定Principal Investigator
- Principal Investigator
  
  伊藤恭悟
- Project Period (FY)
  1995
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Kurume University
Development of cancer vaccine with MAGE gene products.Principal Investigator
- Principal Investigator
  
  ITOH Kyogo
- Project Period (FY)
  1995 – 1996
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Digestive surgery
- Research Institution
  Kurume University
Expression of MAGE gene in esophageal carcinomas and its clinical application
- Principal Investigator
  
  TOH Yuji
- Project Period (FY)
  1995 – 1997
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Kurume University
Expression of MAGE tumor rejection antigen on lung cancer and application for cancer vaccine
- Principal Investigator
  
  SHICHIJO Shigeki
- Project Period (FY)
  1995 – 1996
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Thoracic surgery
- Research Institution
  Kurume University
ヒト自家癌拒絶の免疫学的分子機構
- Principal Investigator
  
  菊地浩吉
- Project Period (FY)
  1994
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Sapporo Medical University
ヒトがん特異的T細胞抗原レセプター遺伝子の解析Principal Investigator
- Principal Investigator
  
  伊東恭悟
- Project Period (FY)
  1994
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Kurume University
ヒトがん特異的T細胞抗原レセプター遺伝子の解析Principal Investigator
- Principal Investigator
  
  伊東恭悟
- Project Period (FY)
  1993
- Research Category
  
  Grant-in-Aid for Cancer Research
- Research Institution
  Kurume University
Expression of MAGE genes on human colon cancers and its biological significance.
- Principal Investigator
  
  FUJIWARA Ryoichi
- Project Period (FY)
  1993 – 1994
- Research Category
  
  Grant-in-Aid for General Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Kurume University School of Medicine

[Book] Cancer Immunology:Cancer Immunotherapy for Organ-Specific Tumors2015
- Author(s)
  Uhi Toh, Tetsuro Sasada, Ryuji Takahashi, Kyogo Itoh, and Yoshito Akagi,
- Publisher
  ©Springer-Verlag Berlin Heidelberg
- Data Source
  KAKENHI-PROJECT-26461965
[Book] Tumor Immunology Series, pp 75-96((Ed.) Stauss H. Kawakami, Parmiani G)2003
- Author(s)
  Kyogo Itoh., et al.
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Immune-related adverse events are clinical biomarkers to predict favorable outcomes in advanced renal cell carcinoma treated with nivolumab plus ipilimumab2022
- Author(s)
  Ueda Kosuke、Suekane Shigetaka、Kurose Hirofumi、Ito Naoki、Ogasawara Naoyuki、Hiroshige Tasuku、Chikui Katsuaki、Ejima Kazuhisa、Uemura Keiichiro、Nakiri Makoto、Nishihara Kiyoaki、Igawa Tsukasa
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 1 Issue: 5 Pages: 1-8
- DOI
  10.1093/jjco/hyac009
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09182, KAKENHI-PROJECT-20K18128
[Journal Article] Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR2021
- Author(s)
  Kobayashi Takashi、Ito Katsuhiro、Suekane Shigetaka、Nagasawa Seiji、Higashi Shin、Fukui Tomohiro、Ogawa Osamu、Kitamura Hiroshi、Nishiyama Hiroyuki
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 71 Issue: 2 Pages: 461-471
- DOI
  10.1007/s00262-021-03000-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09182
[Journal Article] Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial2020
- Author(s)
  Noguchi Masanori、Arai Gaku、Egawa Shin、Ohyama Chikara、Naito Seiji、Matsumoto Kazumasa、Uemura Hirotsugu、Nakagawa Masayuki、Nasu Yasutomo、Eto Masatoshi、Suekane Shigetaka、Sasada Tetsuro、Shichijo Shigeki、Yamada Akira、Kakuma Tatsuyuki、Itoh Kyogo
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 69 Issue: 5 Pages: 847-857
- DOI
  10.1007/s00262-020-02498-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09182, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-18K19490
[Journal Article] Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients2020
- Author(s)
  Suekane Shigetaka、Yutani Shigeru、Yamada Akira、Sasada Tetsuro、Matsueda Satoko、Takamori Shinzo、Toh Uhi、Kawano Kouichiro、Yoshiyama Koichi、Sakamoto Shinjiro、Sugawara Shunichi、Komatsu Nobukazu、Yamada Teppei、Naito Masayasu、Terasaki Mizuhiko、Mine Takashi、Itoh Kyogo、Shichijo Shigeki、Noguchi Masanori
- Journal Title
  
  International Journal of Oncology
  
  Volume: 56 Pages: 1479-1489
- DOI
  10.3892/ijo.2020.5019
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09182, KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-18K19490
[Journal Article] Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers2018
- Author(s)
  Masanori Noguchi, Noriko Koga, Fukuko Moriya, Shigetaka Suekane, Shigeru Yutani, Akira Yamada, Shigeki Shichijo, Tatuyuki Kakuma, Kyogo Itoh
- Journal Title
  
  Cancer Science
  
  Volume: 109 Issue: 9 Pages: 2660-2669
- DOI
  10.1111/cas.13709
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K09182
[Journal Article] Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer.2017
- Author(s)
  Okabe M, Toh U, Iwakuma N, Saku S, Akashi M, Kimitsuki Y, Seki N, Kawahara A, Ogo E, Itoh K, Akagi Y.
- Journal Title
  
  Cancer Sci.
  
  Volume: 108 Issue: 1 Pages: 81-90
- DOI
  10.1111/cas.13114
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-15K10078, KAKENHI-PROJECT-26461965
[Journal Article] Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma.2017
- Author(s)
  Suekane S, Ueda K, Nishihara K, Sasada T, Yamashita T, Koga N, Yutani S, Shichijo S, Itoh K, Igawa T, Noguchi M.
- Journal Title
  
  Cancer Sci.
  
  Volume: 108 Issue: 12 Pages: 2430-2437
- DOI
  10.1111/cas.13404
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04278, KAKENHI-PROJECT-15K10614, KAKENHI-PROJECT-16K15601
[Journal Article] Breast Cancer Resistance to Antiestrogens Is Enhanced by Increased ER Degradation and ERBB2 Expression.2017
- Author(s)
  Shibata T, Watari K, Izumi H, Kawahara A, Hattori S, Fukumitsu C, Murakami Y, Takahashi R, Toh U, Ito KI, Ohdo S, Tanaka M, Kage M, Kuwano M, Ono M.
- Journal Title
  
  Cancer Res.
  
  Volume: 77(2) Pages: 545-556
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26461965
[Journal Article] トリプルネガティブ乳がんに対する混合ペプチドワクチン（KRM-19）療法の臨床的検討2016
- Author(s)
  唐　宇飛、朔　周子、岡部実奈、岩熊伸高、君付優子、赤司桃子、淡河恵津世、山田　亮、七條茂樹、伊東恭悟、赤木由人
- Journal Title
  
  癌と化学療法
  
  Volume: 43（10） Pages: 1249-1251
- Data Source
  KAKENHI-PROJECT-26461965
[Journal Article] Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele.2015
- Author(s)
  Sakamoto S, Matsueda S, Takamori S, Toh U, Noguchi M, Yutani S, Yamada A, Shichijo S, Yamada T, Suekane S, Kawano K, Sasada T, Hattori N, Kohno N, Itoh K.
- Journal Title
  
  Cancer Sci.
  
  Volume: 106 Issue: 10 Pages: 1257-1263
- DOI
  10.1111/cas.12757
- NAID
  120006799352
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461965, KAKENHI-PROJECT-15H04831, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176
[Journal Article] 転移再発乳癌におけるCTC 測定意義に関する検討2015
- Author(s)
  岡部実奈,唐宇飛,岩熊伸高,三島麻衣,松枝智子,七條茂樹,伊東恭悟,赤木由人
- Journal Title
  
  癌と化学療法
  
  Volume: 42（10） Pages: 1237-1239
- Data Source
  KAKENHI-PROJECT-26461965
[Journal Article] Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients.2014
- Author(s)
  Takahashi R, Toh U, Iwakuma N, Takenaka M, Otsuka H, Furukawa M, Fujii T, Seki N, Kawahara A, Kage M, Matsueda S, Akagi Y, Yamada A, Itoh K, Sasada T.
- Journal Title
  
  Breast Cancer Res.
  
  Volume: 16 Issue: 4 Pages: 00-00
- DOI
  10.1186/bcr3685
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23591914, KAKENHI-PROJECT-24591925, KAKENHI-PROJECT-26293293, KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-26461965
[Journal Article] Moleculary-Targeted Therapeutic Strategies for Breast Cancer Focusing on HER”-Targeted Therapy,mTOR Inhibitor and Antiangiogenic Therapy2014
- Author(s)
  Teruhiko Fujii,Keisuke Miwa,Tomoyuki Ushijima,Mototsugu Matsunaga,Masaru Fukahori,Kotaro Yuge,Uhi Toh,Nobutaka Iwakuma,Ryuji Takahashi,Hiroki Takahashi,Miki Takenaka,Mai Mishima,Yoshito Akagi,Masayoshi Kage,Shino Nakagawa,Maki Tanaka
- Journal Title
  
  Frontiers in Anti-Cancer Drug Discovery
  
  Volume: 4 Pages: 157-228
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26461965
[Journal Article] Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer2014
- Author(s)
  Mai Mishima,Uhi Toh, Nobutaka Iwakuma,Miki Takenaka, Mina Furukawa, Yoshito Akagi
- Journal Title
  
  Breast Cancer
  
  Volume: 8 Pages: 00-00
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26461965
[Journal Article] Overcoming the hurdles of randomized clinical trials of therapeutic cancer vaccines.(発表論文10)2010
- Author(s)
  Sasada T, Komatsu N, Suekane S, Yamada A., Masanori N, Itoh K.
- Journal Title
  
  European J.Cancer (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients.(発表論文9)2010
- Author(s)
  Yanagimoto H, Shiomi H, Satoi S, Mine T, Toyokawa H, Yamamoto T, Tani T, Yamada A, Kwon A-Hon, Komatsu N, Itoh K, Noguchi M
- Journal Title
  
  Oncology Reports (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate(EMP)versus standard dose EMP in patients with castration resistant prostate cancer.(発表論文7)2010
- Author(s)
  Noguchi M, Kakuma T, Uemura H, Nasu Y, Kumon H, Hirao Y, Moriya F, Suekane S, Matsuoka K, Komatsu N, Shichijo S, Yamada A, Itoh, K
- Journal Title
  
  Cancer Immunol.Immunotherapy (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Prophylactic effect of peptide vaccination against hepatocellular carcinoma associated with hepatitis C virus(発表論文8)2010
- Author(s)
  Komatsu N, Yutani S, Yamada A, Shichijo S, Yoshida K, Itou M, Kuromatsu R, Ide T, Tanaka M, Sata M, Itoh K
- Journal Title
  
  Experimental and Therapeutic Medicine (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer2010
- Author(s)
  Noguchi M, Kakuma T, Uemura H, Nasu Y, Kumon H, Hirao Y, Moriya F, Suekane S, Matsuoka K, Komatsu N, Shichijo S, Yamada A, Itoh K
- Journal Title
  
  Cancer Immunol. Immunotherapy (in press)
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metatatic colorectal carcinoma patients2009
- Author(s)
  Hattori T, Itoh K, et.al.
- Journal Title
  
  Cancer Immunology and Immunothrerapy (In press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Capability of SART3_<109-118> peptide to induce cytotoxic T lymphocytes from prostate cancer patients with HLA class I-A11, -A31 and -A33 alleles.(発表論文1)2009
- Author(s)
  Mohamed ER, Naito M, Terasaki Y, Niu Y, Gohara S, Komatsu N, Shichijo S, Itoh K, Noguchi M
- Journal Title
  
  Int J Oncol 34
  
  Pages: 529-36
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen class-I-A alleles.(発表論文5)2009
- Author(s)
  Yutani S, Komatsu N, Shichijo S, Yoshida K, Takedatsu H, Itou M, Kuromatu R, Ide T, Tanaka M, Sata M, Yamada A, Itoh K
- Journal Title
  
  Cancer Sci 100
  
  Pages: 1935-1942
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients.(発表論文6)2009
- Author(s)
  Niu Y, Terasaki Y, Komatsu N, Noguchi M, Shichijo S, Itoh K
- Journal Title
  
  Cancer Sci. 100
  
  Pages: 2167-74
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] A peptide derived from hepatitis C virus(HCV)cote protein inducing cellular responses in patients with HCV with various HLA class IA alleles.(発表論文4)2009
- Author(s)
  Niu Y, Komatsu N, Komohara Y, Matsueda S, Yutani S, Ishihara Y, Itou M, Yamada A, Itoh K, Shichijo S
- Journal Title
  
  J Med Virol 81
  
  Pages: 1232-1240
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Defucosylated anti-CCR4 monocljonal antibody exerts potent ADCC against primary ATLL cell mediated by autologous human immune cells inNOD/Shi-scid, IL-2R qamma(null) mice in vivo.2009
- Author(s)
  Ito A
- Journal Title
  
  J Immunol 183(7)
  
  Pages: 4782-4791
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16062101
[Journal Article] Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients2009
- Author(s)
  Hattori T, Mine T, Komatsu N, Yamada A, Itoh K, Shiozaki H, Okuno K
- Journal Title
  
  Cancer Immunol. Immunotherapy. 58
  
  Pages: 1843-52
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Recent advances in cancer vaccines : an overview2009
- Author(s)
  Itoh K, et.al.
- Journal Title
  
  Jpn J Clin Oncol 39
  
  Pages: 73-80
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles.(発表論文2)2009
- Author(s)
  Terasaki Y, Shichijo S, Niu Y, Komatsu N, Noguchi M, Todo S, Itoh K
- Journal Title
  
  Cancer Immunol Immunother 58
  
  Pages: 1877-1885
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients.(発表論文3)2009
- Author(s)
  Hattori T, Mine T, Komatsu N, Yamada A, Itoh K, Shiozaki H, Okuno K
- Journal Title
  
  Cancer Immunol Immunother 58
  
  Pages: 1843-52
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Capability of SART3_<109-118>peptide to induce cytotoxic T-lymphocytes from prostate cancer patients with HLA class I-All,-A31, and-A33 alleles2009
- Author(s)
  Mohamed ER, Itoh K, et.al.
- Journal Title
  
  Int J Oncol 34
  
  Pages: 529-36
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+malignant glioma patients2008
- Author(s)
  Jin M, Itoh K, et.al.
- Journal Title
  
  Oncol Rep 19
  
  Pages: 1277-1283
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] A correlation between symptom severity and unbalanced reactive IgA production in Japanese cedar pollinosis patients2008
- Author(s)
  Komatsu N, Itoh K, et.al.
- Journal Title
  
  Asian Pac J Allergy Immunol 26
  
  Pages: 97-104
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients2008
- Author(s)
  Naito M, Itoh K, et.al.
- Journal Title
  
  Prostate 68
  
  Pages: 1753-62
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Detection of IgE antibody specific to a hepatitis C virus-derived peptide being recognized by cellular immunity in patients with HCV infection2008
- Author(s)
  Gohara S, Itoh K, et.al.
- Journal Title
  
  Viral Immunology 21
  
  Pages: 365-389
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms2008
- Author(s)
  Noguchi M, Itoh K, et.al.
- Journal Title
  
  Asian J Androl 10
  
  Pages: 777-785
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+glioma patients2008
- Author(s)
  Jin M, Itoh K, et.al.
- Journal Title
  
  Cancer Sci 99
  
  Pages: 1656-62
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection,while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients2007
- Author(s)
  Takao Y, Itoh K, et. al.
- Journal Title
  
  Med Microbiol Immunol 196
  
  Pages: 157-164
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of SART3-derived peptides having the potential to induse cancer-reactive Cytotoxic T Lymphocytes from prostate cancer patients with HLA-A3 super type alleles.2007
- Author(s)
  Minami T, Itoh K, et al.
- Journal Title
  
  Cancer Immunol Immunother. (In press)
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles2007
- Author(s)
  Naito M, Komohara Y, Ishihara Y, Noguchi M, Yamashita y, Shirakusa T, Yamada A, Itoh K, Harada M
- Journal Title
  
  British J Cancer 97
  
  Pages: 1648-1654
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivativ(TS-1)for advanced gastric or colorectal carcinoma patients2007
- Author(s)
  SatoY, Itoh K, et. al.
- Journal Title
  
  Can.Science 98
  
  Pages: 1113-1119
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of new immunogenic peptides in conserved regions of hepatitis C virus(HCV)lb that can induce both cellular and humoral immunity in HCVlb+HLA-A24+patients.2007
- Author(s)
  Takao Y, Itoh K, et. al.
- Journal Title
  
  Hepatol Res 37
  
  Pages: 186-195
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] A new epitope peptide derived from hepatitis C virus lb possessing the capacity to induce cytotoxic T-lymphocytes in HCVlb-infected patients with HLA-All,-A31and-A33.2007
- Author(s)
  Natsueda S, Itoh K, et. al.
- Journal Title
  
  Cancer Immunol Immunother. 56
  
  Pages: 1359-66
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of a peptide derived from HCV inducing cellular responses with various HLA class I -A alleles.2007
- Author(s)
  Shichijo S, Komohara Y, Matsueda S, Yutani S, Komatsu N, Sata M, Yamada A, Itoh K
- Journal Title
  
  The 66th Annual Meeting of the Japanese Cancer Association.(Yokohama) 10/3-5
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Increased levels of IgG antibodies against peptides of prostate stem cell antigen in the plasma of pancreatic cancer patients.2007
- Author(s)
  Tanaka M, Itoh K, et. al.
- Journal Title
  
  Oncol Rep 18
  
  Pages: 161-166
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Expression of APOBC3G in kidney cells.2007
- Author(s)
  Komohara Y, Itoh K, et. al.
- Journal Title
  
  Tissue Antigens 69
  
  Pages: 95-98
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus(HCV)1b who failed to respond to interferon-based therapy2007
- Author(s)
  Yutani S, Itoh K, et. al.
- Journal Title
  
  Vaccine 25
  
  Pages: 7429-35
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Serum levels of IgG to the peptide of HCVlb core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.2007
- Author(s)
  Takao Y, Yamada A, Yutani S, Ono T, Nagao Y, Ando E, Ide T, Itoh K, Sata M
- Journal Title
  
  Med Microbiol Immunol. 196
  
  Pages: 157-164
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Differential levels of human leukocyte antigen-class I,multidrug-resistancel and androgen receptor expressions in untreated prostate cancer cells:the robustness of prostate cancer.2007
- Author(s)
  Homma S, Itoh K, et. al.
- Journal Title
  
  Oncol Res 18
  
  Pages: 343-346
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of SART3-derived peptides having the potential to induse cancer-reactive Cytotoxic T Lymphocytes from prostate cancer patients with HLA-A3 super type alleles.2007
- Author(s)
  Minami T, Itoh K, et. al.
- Journal Title
  
  Cancer Immunol Immunother. 56
  
  Pages: 689-698
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] New peptides of the polycomb group protein enhancer of zeste homolog 2with the potential to induce cancer-reactive cytotoxic T lymphocytes in humanleukocyte antigen-A2+prostate cancer patients.2007
- Author(s)
  Itoh Y, Utoh K, et. al.
- Journal Title
  
  Oncology Reports 18
  
  Pages: 1231-1237
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Combination therapy of personalized peptide vaccination with low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients:an analysis of prognostic factors in the treatment2007
- Author(s)
  Noguchi M, Itoh K, et. al.
- Journal Title
  
  Oncol Res 16
  
  Pages: 341-349
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b that can induce both cellular and humoral immunity in HCV1b+HLA-A24+ patients.2007
- Author(s)
  Takao Y, Itoh K, et al.
- Journal Title
  
  Hepatology Research (In press)
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] tionSerum levels of IgG to the peptide of HCV 1b core at positions 35-44 correlated with persistent infecyion, while levels of IgG to the peptide of NS5A at posi 2132-2140 correlated with better prognosis in HCV-inferected patients2007
- Author(s)
  Takao Y, Itoh K, et. al.
- Journal Title
  
  Med Microbiol Immunol 196
  
  Pages: 157-164
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancer.2007
- Author(s)
  Noguchi M, Itoh K et al.
- Journal Title
  
  Prostate (in press)
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Phase I clinical study of a personalized peptide vaccination for patients intected with hepatitis C virus(HCV)lb who failed to respond to interferon-based therapy.2007
- Author(s)
  Yutani S, Itoh K, et. al.
- Journal Title
  
  Vaccine 25
  
  Pages: 7429-35
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancer.2007
- Author(s)
  Noguchi M, Itoh K, et. al.
- Journal Title
  
  Prostate 67
  
  Pages: 933-942
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Serum levels of IgG to the peptide of HCV-1b core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at position 2132-2140 correlated with better prognosis in HCV-infected patients.2007
- Author(s)
  Takao Y, Itoh K, et al.
- Journal Title
  
  Medical Microbiol.Immunol. (In press)
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Combination therapy of personalized peptide vaccination with low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients : an analysis of prognostic factors in the treatment.2007
- Author(s)
  Noguchi M, Mine T, Yamada A, Obata Y, Yoshida K, Mizoguchi J, Harada M, Suekane S, Itoh K, Matuoka K
- Journal Title
  
  Oncol Res 16
  
  Pages: 341-349
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles2007
- Author(s)
  Matsueda S, Itoh K, et. al.
- Journal Title
  
  J Immunother 30
  
  Pages: 274-281
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles.2007
- Author(s)
  Matsueda S, Takedatsu H, Sasada T, Azuma K, Ishihara Y, Komohara Y, Noguchi M, Shichijo S, Itoh K, Harada M
- Journal Title
  
  J Immunother 30
  
  Pages: 274-281
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Combination therapy of personalized peptide vaccination with low-doseestramustine phosphate for metastatic hormone refractory prostate cancer patients: an analsis of pronostic factors in the treatment2007
- Author(s)
  Noguchi M, Itoh K, et. al.
- Journal Title
  
  Oncol Res 16
  
  Pages: 341-349
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivativ(TS-1) for advanced gastric or colorectal carcinoma patients.2007
- Author(s)
  Sato Y, Itoh K et al.
- Journal Title
  
  Can. Science (in press)
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Phase I clinical study of a presonalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy2007
- Author(s)
  Yutani S, Itoh K, et. al.
- Journal Title
  
  Vaccine 25
  
  Pages: 7429-7435
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Combination therapy of personalized peptide vaccination with a low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients:an analysis of prognostic factors in the treatment.2007
- Author(s)
  Noguchi M, Itoh K, et. al.
- Journal Title
  
  Oncol Res 16
  
  Pages: 341-349
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles.2007
- Author(s)
  Matsueda S, Takedatsu H, Sasada T, Azuma K, Ishihara Y, Komohara Y, Noguchi M, Shichijo S, Itoh K, Harada M
- Journal Title
  
  J Immunother 30
  
  Pages: 274-81
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] New peptide vaccine candidates for epithelial cancer patients with HLA-A3supertype alleles.2007
- Author(s)
  Matsueda S, Itoh K, et. al.
- Journal Title
  
  J Immunother 30
  
  Pages: 274-281
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles2007
- Author(s)
  Naito M, Itoh K, et. al.
- Journal Title
  
  British J Cancer 97
  
  Pages: 1648-1654
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Personalized peptide vaccination for cancer patient.2007
- Author(s)
  Itoh K, Noguti M, Yamanaka R, Yamada A, Shichijo S
- Journal Title
  
  The 27th General Assembly of the Japan Medical Congress.(Osaka) 4/6-8
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles2007
- Author(s)
  Minami T, Itoh K, et. al.
- Journal Title
  
  Cancer Immunol Immunother 56
  
  Pages: 689-698
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer.2007
- Author(s)
  Yanagimoto Y, Itoh K et al.
- Journal Title
  
  Can. Science (in press)
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer.2007
- Author(s)
  Yanagimoto Y, Itoh K, et. al.
- Journal Title
  
  Can.Science 98
  
  Pages: 605-611
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Expression of APOBEC3G in kidney cells2007
- Author(s)
  Komohara Y, Itoh K et al.
- Journal Title
  
  Tissue Antigens (in press)
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles.,2007
- Author(s)
  Naito M, , Itoh K, et. al.
- Journal Title
  
  British J Cancer 97
  
  Pages: 1648-1654
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Kinesin superfamily.protein-derived peptides with the ability toinduce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A24+ glioma patients.2007
- Author(s)
  Harada M, Itoh K, et. al.
- Journal Title
  
  Oncol Rep. 15
  
  Pages: 629-636
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.2007
- Author(s)
  Minami T, Matsueda S, Takedatsu H, Tanaka M, Noguchi M, Uemura H, Itoh K, Harada M
- Journal Title
  
  Cancer Immunol Immunother. 56
  
  Pages: 689-698
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Development of a new diagnostic tool for pancreatic cancer, Increased levels of IgG against peptides of prostate stem cell antigen in pancreatic cancer patients.2007
- Author(s)
  Tanaka M, Itoh K et al.
- Journal Title
  
  Oncology Report (in press)
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus(HCV) lb who failed to respond to interferon-based therapy.2007
- Author(s)
  Yutani S, Yamada A, Yoshida K, Takao Y, Tamura M, Komatsu N, Ide T, Tanaka M, Sata M, Itoh K
- Journal Title
  
  Vaccine 25
  
  Pages: 7429-35
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Combined therapy of personalized peptide vaccination with a low dose of estramustine phosphate for horumone refractory prostate cancer patients : an analysis of prognostic factors in the treatment.2007
- Author(s)
  Noguchi M, Itoh K et al.
- Journal Title
  
  Oncology Research 16
  
  Pages: 1-10
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Differential levels of human leukocyte antigen-class 1, multidrug-resistance 1, and androgen receptor expressions in untreated prostate cancer cells : the robustness of prostate cancer.2007
- Author(s)
  Homma S, Itoh K et al.
- Journal Title
  
  ONCOLOGY RES. (in press)
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11,-A31 and -A332007
- Author(s)
  Matsueda S, Itoh K, et. al.
- Journal Title
  
  Cancer Immunol Immunother 56
  
  Pages: 1359-66
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A24+ glioma patients.2007
- Author(s)
  Harada M, Itoh K et al.
- Journal Title
  
  Oncol Rep 15
  
  Pages: 629-636
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] HLA-G as a target molecule in specific immunotherapy against renalcell carcinoma.2007
- Author(s)
  Komohara Y, Itoh K, et. al.
- Journal Title
  
  Oncology Report 18
  
  Pages: 1463-1468
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patioents with HLA-All, -A31 and -A332007
- Author(s)
  Matsueda S, Itoh K, et. al.
- Journal Title
  
  Cancer Immunol Immunother 56
  
  Pages: 1359-1366
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of target antigens in specific immunotherapy for renal cell carcinoma.2007
- Author(s)
  Komohara Y, Itoh K et al.
- Journal Title
  
  J Urol. 177
  
  Pages: 1157-1162
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Serum levels of IgG to the peptide of HCVlb vore at positions 35-44correlated with persistent infection,while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.2007
- Author(s)
  Takao Y, Itoh K, et. al.
- Journal Title
  
  Med Microbiol Immunol. 196
  
  Pages: 157-164
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of Lck-derived peptides applicable to anti-cancer vaccine-for patients with human leukogyte antigen-A3 supertype alleles2007
- Author(s)
  Naito M, Itoh K, et. al.
- Journal Title
  
  British J Cancer 97
  
  Pages: 1648-1654
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of SART3-dehved peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles2007
- Author(s)
  Minami T, Itoh K, et. al.
- Journal Title
  
  Cancer Immunol Immunother 56
  
  Pages: 689-698
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] A new epitope peptide derived from hepatitis C virus lb possessing the capacity to induce cytotoxic T-lymphocytes in HCVlb-infected patients with HLA-A11, -A31 and -A33.2007
- Author(s)
  Matsueda S, Yamada A, Takao Y, Tamura M, Komatsu N, Yutani S, Ide T, Sata M, Itoh K
- Journal Title
  
  Cancer Immunol Immunother. 56
  
  Pages: 1359-66
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of target antigens in specific immunotherapy for renal cell carcinoma.2007
- Author(s)
  Komohara Y, Itoh K, et. al.
- Journal Title
  
  J Urol. 177
  
  Pages: 1157-1162
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of Lek-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles.2007
- Author(s)
  Naito M, Komohara Y, Ishihara Y, Noguchi M, Yamashita Y, Shirakusa T, Yamada A, Itoh K, Harada M
- Journal Title
  
  British J Cancer 97
  
  Pages: 1648-1654
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Nonmutated Self-Antigen-Derived Cancer Vaccine Peptides Elicit an IgE-Independent but Mast Cell-Dependent Immediate-Type Skin Reaction withoutSystemic Anaphylaxis.2006
- Author(s)
  Yamada, A., Itoh, K., et al.
- Journal Title
  
  J Immunol. 176 (2)
  
  Pages: 857-863
- Data Source
  KAKENHI-PROJECT-16062101
[Journal Article] Identification of hepatitis C virus(HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.2006
- Author(s)
  Wang Y, Takao Y, Harada M, Komatsu N, Ono T, Sata M, Itoh, K, Yamada A
- Journal Title
  
  Cell Immunol 241
  
  Pages: 38-46
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma2006
- Author(s)
  Uemura H, Fujimoto K, Tanaka M, Yoshikawa M, Hirao Y, Uejima S, Yoshikawa K, Itoh K.
- Journal Title
  
  Clin Cancer Res. 12
  
  Pages: 1768-75
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Anti-tumor effects of systemic and local immunization with a cytotoxic T lymphocyte-directed peptide in combination with a local injection of OK-4322006
- Author(s)
  Ono T, Harada M, Yamada A, Tanaka M, Takao Y, Tanaka Y, Mine T, Sakamoto K, Nakashima T, Itoh K.
- Journal Title
  
  Clin Cancer Res. 12
  
  Pages: 1325-32
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma.2006
- Author(s)
  Uemura H, Itoh K et al.
- Journal Title
  
  Clin Cancer Res 12
  
  Pages: 1768-1775
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Anti-tumor effects of systemic and local immunization with a cytotoxic T lymphocyte-directed peptide in combination with a local injection of OK-4322006
- Author(s)
  Ono T, Harada M, Itoh K, et al.
- Journal Title
  
  Clin Cancer Res. 12:
  
  Pages: 1325-1332
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis.2006
- Author(s)
  Yamada A, Yano H, Takao Y, Ono T, Matsumoto T, Itoh K
- Journal Title
  
  J Immunol 176
  
  Pages: 857-863
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] High expression ofAPOBEC3G in patients infected with hepatitis C virus.2006
- Author(s)
  Komohara Y, Itoh K et al.
- Journal Title
  
  J Mol Histol. 37
  
  Pages: 327-332
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Keratinocyte growth factor transduction ameliorates acute lung injury and mortality in mice.2006
- Author(s)
  Baba, Y., Saito, I., et al.
- Journal Title
  
  Hum Gene Ther. 18(2)
  
  Pages: 130-141
- Data Source
  KAKENHI-PROJECT-16062101
[Journal Article] Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis.2006
- Author(s)
  Yamada A., Itoh K et al.
- Journal Title
  
  J Immunol. 176
  
  Pages: 857-863
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte anitigen-A24+and HCV2a-infected patients.2006
- Author(s)
  Wang Y, Itoh K, et al.
- Journal Title
  
  Cell Immunol. 241
  
  Pages: 38-46
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Development of a new diagnostic tool for pancreatic cancer : simultaneous measurement of antibodies against peptides recognized by cytotoxic T lymphocytes.2006
- Author(s)
  Tanaka M, Itoh K et al.
- Journal Title
  
  Kurume Med J 53
  
  Pages: 63-70
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patients.2006
- Author(s)
  Wang Y, Itoh K et al.
- Journal Title
  
  Oncol Rep. 15
  
  Pages: 317-321
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinoma.2006
- Author(s)
  Komohara Y, Itoh K et al.
- Journal Title
  
  Int J Oncol. 29
  
  Pages: 1555-1560
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patients.2006
- Author(s)
  Wang Y, Harada M, Itoh K, et al.
- Journal Title
  
  Oncol Rep. 15
  
  Pages: 317-321
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction with out systemic anaphylaxis2006
- Author(s)
  Yamada A., Yano H., Itoh K, et al.
- Journal Title
  
  J Immunol, 176
  
  Pages: 857-863
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432.2006
- Author(s)
  Ono T, Itoh K et al.
- Journal Title
  
  Clin Cancer Res. 12
  
  Pages: 1325-1332
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] New epitope peptides derived from hepatitis C virus(HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.2006
- Author(s)
  Wang Y, Takao Y, Harada M, Yutani S, Ide T, Sata M, Itoh K, Yamada A
- Journal Title
  
  Microbiol Immunol 50
  
  Pages: 857-865
- NAID
  10018398215
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.2006
- Author(s)
  Wang Y, Itoh K, et al.
- Journal Title
  
  Microbiol Immunol. 50
  
  Pages: 857-865
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis.2006
- Author(s)
  Yamada A., Itoh K., et al.
- Journal Title
  
  J Immunol. 176
  
  Pages: 857-863
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.2006
- Author(s)
  Wang Y, Itoh K et al.
- Journal Title
  
  Cell Immunol. 241
  
  Pages: 38-46
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.2006
- Author(s)
  Sugita S, Itoh K et al.
- Journal Title
  
  IOVS 47
  
  Pages: 2547-2554
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis2006
- Author(s)
  Yamada A, Yano H, Takao Y, Ono T, Matsumoto T, Itoh K.
- Journal Title
  
  J Immunol. 176
  
  Pages: 857-63
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of squamous cell carcinoma antigen-derived peptides having the capacity of inducing cancer-reactive CTLs in HLA-A24+ cancer patients.2006
- Author(s)
  Homma S, Itoh K et al.
- Journal Title
  
  Int. J. Oncology 29
  
  Pages: 577-587
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432.2006
- Author(s)
  Ono T, Harada M, Yamada A, Tanaka M, Takao Y, Tanaka Y, Mine T, Sakamoto K, Nakashima T, Itoh K
- Journal Title
  
  Clin Cancer Res 12
  
  Pages: 1325-1332
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Journal Article] Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.2005
- Author(s)
  Matsueda S., Takedatsu H., Itoh K, et al.
- Journal Title
  
  Clin Cancer Res. 11
  
  Pages: 6933-6943
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Determination of thrombopoietin-derived peptides recognized by both cellular and humoral immunities in healthy donors and patients with thrombocytopenia.2005
- Author(s)
  Takedatsu H, Yoshimoto K, Itoh K, et al.
- Journal Title
  
  Stem Cells 23
  
  Pages: 975-982
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with non-prostate adenocarcinoma.2005
- Author(s)
  Wang Y, Harada M, Itoh K, et al.
- Journal Title
  
  J Immunother 28(6)
  
  Pages: 535-541
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of human papillomavirus 16 E6 protein-derived peptides with the potential to generate cytotoxic T lymphocytes toward HLA-A24+ cervical cancer.2005
- Author(s)
  Hara M., Matsueda S., Itoh K, et al.
- Journal Title
  
  Int J Oncol. 27(5)
  
  Pages: 1371-1379
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.2005
- Author(s)
  Matsueda S, Takedatsu H, Yao A, Tanaka M, Noguchi M, Itoh K.
- Journal Title
  
  Clin Cancer Res. 11
  
  Pages: 6933-43
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Immunological evaluation of vaccination of peptides derived from epithelial cancer-related antigens in two patients with hematological malignancy.2005
- Author(s)
  Takedatsu H, Yoshimoto K, Itoh K, et al.
- Journal Title
  
  International journal of oncology 26
  
  Pages: 1605-1612
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients.2005
- Author(s)
  Noguchi M, Itoh K, et al.
- Journal Title
  
  Prostate 63
  
  Pages: 1-12
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Vaccination of cytotoxic T lymphocyte-directed peptides elicited and spread humoral and Th1-type immune responses to prostate-specific antigen protein in a prostate cancer patient2005
- Author(s)
  Harada M, Matsueda S, Yao A, Noguchi M, Itoh K
- Journal Title
  
  J Immunother 28
  
  Pages: 368-75
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Determination of thrombopoietin-derived peptides recognized by both cellular and humoral immunities in healthy donors and patients with thrombocytopenia2005
- Author(s)
  Takedatsu H, Yoshimoto K, Okamura T, Miyazaki H, Kuwaki T, Sata M, Itoh K.
- Journal Title
  
  Stem Cells 23
  
  Pages: 975-82
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Parathyroid hormone-related protein as a common target molecule in specific immunotherapy for a wide variety of tumor types.2005
- Author(s)
  Arima Y, Matsueda S, Itoh K, et al.
- Journal Title
  
  Int J Oncology 27
  
  Pages: 981-988
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Vaccination of cytotoxic T lymphocyte-directed peptides elicited and spread humoral and Th1-type immune responses to prostate-specific antigen protein in a prostate cancer patient.2005
- Author(s)
  Harada M, Matsueda S, Itoh K, et al.
- Journal Title
  
  Journal of Immunotherapy 28
  
  Pages: 368-375
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Immunological and clinical evaluation of personalized peptide vaccination for Patients with advanced malignant glioma.2005
- Author(s)
  Yajima N, Yamanaka R, Itoh K, et al.
- Journal Title
  
  Clinical Cancer Research 11
  
  Pages: 5900-5911
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] ABCE1, a member of ATP-binding cassette transporter gene, encodes peptides capable of inducing HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes in colon cancer patients.2005
- Author(s)
  Shichijo S, Ishihara Y, Itoh K, et al.
- Journal Title
  
  Oncology Reports 13
  
  Pages: 907-913
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.2005
- Author(s)
  Matsueda, S., Itoh, K.et al.
- Journal Title
  
  Clin Cancer Res. 11
  
  Pages: 6933-6943
- Data Source
  KAKENHI-PROJECT-16062101
[Journal Article] New Epitope Peptides Derived From Parathyroid Hormone-Related Protein Which Have the Capacity to Induce Prostate Cancer-Reactive Cytotoxic T Lymphocytes in HLA-A2^+ Prostate Cancer Patients.2005
- Author(s)
  Yao A, Harada M, Itoh K, et al.
- Journal Title
  
  The Prostate 62
  
  Pages: 233-242
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] A unique gene having homology with the kinesin family member 18A encodes a tumor-associated antigen recognized by cytotoxic T lymphocytes from HLA-A2^+ colon cancer patients.2005
- Author(s)
  Shichijo S, Ito M, Itoh K, et al.
- Journal Title
  
  Eur J Cancer 41
  
  Pages: 1323-1330
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Production of viral vectors using recombinase-mediated cassette exchange.2005
- Author(s)
  Nakano, M., Saito, I., et al.
- Journal Title
  
  Nucleic Acids Res. 33
- Data Source
  KAKENHI-PROJECT-16062101
[Journal Article] A unique gene having homology with the kinesin family member 18A encodes a tumor-associated antigen recognized by bytotoxic T lymphocytes from HLA-A2+ colon cancer patients.2005
- Author(s)
  Shichijo S., Itoh K., et al.
- Journal Title
  
  Eur. J. Cancer (印刷中)
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma.2005
- Author(s)
  Yajima N, Yamanaka R, Mine T, Tsuchiya N, Honma J, Sano M, Kuramoto T, Obata Y, Komatsu N, Arima Y, Yamada A, Shigemori M, Itoh K, Tanaka R.
- Journal Title
  
  Clin Cancer Res. 11
  
  Pages: 5900-11
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients2005
- Author(s)
  Noguchi M, Itoh K, Yao A, Mine T, Yamada A, Obata Y, Furuta M, Harada M, Siekane S, Matsuoka K.
- Journal Title
  
  Prostate 63
  
  Pages: 1-12
- Data Source
  KAKENHI-PROJECT-17016074
[Journal Article] Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes cytotoxic T-lymphocyte(CTL) epitopes capable of inducing human leukocyte antigen-A33-restricted and tumor-reactive CTLs in gastric eancer patients.2004
- Author(s)
  Sasada T., Itoh, K., et al.
- Journal Title
  
  Cancer Res 64
  
  Pages: 2882-2888
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses. Clin.2004
- Author(s)
  Mine T., Sato, Y.Noguchi M., Sasatomi T., Gohara R., Tsuda N., Tanaka S., Shomura H., Katagiri K., Rikimaru T., Shichijo S., Kamura T., Hashimoto T., Shirouzu K., Yamada A., Todo S., Itoh K., Yamana H.
- Journal Title
  
  Cancer Res. 10
  
  Pages: 929-937
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] In vivo evidence that peptide vaccination can induce HLA-DR-restricted CD4+ T cells reactive to a class I turnor peptide.2004
- Author(s)
  Harada M., Itoh K., et al.
- Journal Title
  
  J Immunol 172
  
  Pages: 2659-2667
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer.2004
- Author(s)
  Shichijo S., Azuma K., Komatsu N., Ito M., Maeda Y., Ishihara Y., Itoh K.
- Journal Title
  
  Clin Cancer Res 10
  
  Pages: 5828-5836
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Ran, a small GTPase gene, encodes CTL epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.2004
- Author(s)
  Azuma K, Sasada T, Takedatsu H, Shomura H, Koga M, Maeda Y, Yao A, Hirai T, Takabayashi A, Shichijo S, Itoh K.
- Journal Title
  
  Clin.Cancer Res. 10
  
  Pages: 6695-6702
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic Tlymphocyte-directsd tumor-associated antigens of HLA-A2+ colon cancer.2004
- Author(s)
  Shichijo S., Itoh K., et al.
- Journal Title
  
  Clin Cancer Res 10
  
  Pages: 5828-5836
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Identification of peptide vaccine candidates sharing among HLA-A3+, -All+, -A31+, and-A33+ cancer patients.2004
- Author(s)
  Takedatsu H., Itoh K., et al.
- Journal Title
  
  Clip Cancer Res 10
  
  Pages: 1112-1120
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes cytotoxic T-lymphocyte(CTL) epitopes capable of inducing human leukocyte antigen-A33-restricted and tumor-reactive CTLs in gastric cancer patients.2004
- Author(s)
  Sasada T., Takedatsu H., Azuma K., Koga M., Maeda Y., Shichijo S., Shoumura H., Hirai T., Takabayashi A., Itoh K.
- Journal Title
  
  Cancer Res 64
  
  Pages: 2882-2888
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Identification of peptide vaccinecandidates sharing among HLA-A3+,-A11+,-A31+ and-A33+ cancer patients. Clin.2004
- Author(s)
  Takedatsu H., Shichijo S., Katagiri K.Sawamizu H., Sata M., Itoh K.
- Journal Title
  
  Cancer Res. 10
  
  Pages: 1112-1120
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.2004
- Author(s)
  Takashi M., Itoh K., et al.
- Journal Title
  
  Clin Cancer Res 10
  
  Pages: 929-937
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Immediate early response gene X-l, a stress-inducible antiapoptotic gene, encodes cytotoxic T-lymphocyte(CTL) epitopes capable of inducing human leukocyte antigen-A33-restricted and tumor-reactive CTLs in gastric cancer patients.2004
- Author(s)
  Sasada T., Itoh, K., et al.
- Journal Title
  
  Cancer Res 64
  
  Pages: 2882-2888
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Identification of peptide vaccine candidates sharing among HLA-A3+, -A11+, -A31+, and -A33+ cancer patients.2004
- Author(s)
  Takedatsu, H., Itoh, K.et al.
- Journal Title
  
  Clin.Cancer Res. 10
  
  Pages: 1112-1120
- Data Source
  KAKENHI-PROJECT-16062101
[Journal Article] In vivo evidence that peptide vaccination can induce HLA-DR-restricted CD4+ T cells reactive to a class I tumor peptide.2004
- Author(s)
  Harada M., Gohara R., Matsueda S., Muto A., Oda T., Iwamoto Y., Itoh K.
- Journal Title
  
  J Immunol. 172
  
  Pages: 2659-2667
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Mutated p53 gene encodes a nonmutated epitope recognized by HLA-B 4601-restricted and tumor cell-reactive CTLs at tumor site.2003
- Author(s)
  Azuma K., Shichijo S., Maeda Y., Nakatsura T., Nonaka Y., Fujii T., Koike K., Itoh K.
- Journal Title
  
  Cancer Res. 63
  
  Pages: 854-858
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Gene and peptide analyses of newly defined lung cancer rejection antigens recognized by HLA-A2402-restricted tumor-specific cytotoxic T lymphocytes.2003
- Author(s)
  Yamada A., Kawano K., Koga M., Takamori S., Nakagawa M., Itoh K.
- Journal Title
  
  Cancer Res. 63
  
  Pages: 2829-2835
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Gene and peptide analyses of newly defined lung cancer rejection antigens recognized by HLA-A2402-restricted tumor-specific cytotoxic T lymphocytes.2003
- Author(s)
  Yamada A., Itoh, K., et al.
- Journal Title
  
  Cancer Res 63
  
  Pages: 2829-2835
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Mutated p53 gene encodes a nonmutated epitope recognized by HLA-B 4601-restricted and tumor cell-reactive CTLs at tumor site.2003
- Author(s)
  Azuma K., Itoh, K., et al.
- Journal Title
  
  Cancer Res 63
  
  Pages: 854-858
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method. Eur.2002
- Author(s)
  Nakatsura T., Senju S., Ito M., Nishimura Y., Itoh K.
- Journal Title
  
  J.Immunol. 32
  
  Pages: 826-836
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination with SART3 peptides.2001
- Author(s)
  Miyagi Y., Imai N., Sasatomi T., Yamada A., Mine T., Katagiri K., Nakagawa M., Muto A., Okouchi S., Isomoto H., Shirouzu K., Yamana H., Itoh K.
- Journal Title
  
  Clin.Cancer Res. 7
  
  Pages: 3950-3962
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Molecular basis of T cell-mediated recognition of pancreatic cancer cells.2001
- Author(s)
  Ito M., Shichijo S., Tsuda N., Ochi M., Harashima N., Saito N., Itoh K.
- Journal Title
  
  Cancer Res. 61
  
  Pages: 2038-2046
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Molecular basis of T cell-mediated recognition of pancreatic cancer cells.2001
- Author(s)
  Ito M et al.
- Journal Title
  
  Cancer Res. 61
  
  Pages: 2038-2046
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-11178101
[Journal Article] Multidrug resistance-associated protein 3 is a tumor rejection antigen recognized by HLA-A2402-restricted cytotoxic T lymphocytes.2001
- Author(s)
  Yamada A., Kawano K., Koga M., Matsumoto T., Itoh K.
- Journal Title
  
  Cancer Res. 61
  
  Pages: 6459-6466
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Molecular basis of T cell-mediated recognition of pancreatic cancer cells.2001
- Author(s)
  Ito M., Itoh, K., et al.
- Journal Title
  
  Cancer Res 61
  
  Pages: 2038-2046
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Multidrug resistance-associated protein 3 is a tumor rejection antigen recognized by HLA-A2402-restricted cytotoxic T lymphocytes.2001
- Author(s)
  Yamada A., Itoh, K., et al.
- Journal Title
  
  Cancer Res. 61
  
  Pages: 6459-6466
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer.2000
- Author(s)
  Kawano, K., Itoh, K., et al.
- Journal Title
  
  Cancer Res 60
  
  Pages: 3550-3558
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL.2000
- Author(s)
  Nakao, M., Shichijo, S., Imaizumi, T., Inoue, Y., Matsunaga, K., Yamada, A., Kikuchi, M., Tsuda, N., Ohta, K., Takamori, S., Yamana, H., Fujita, H., Itoh, K.
- Journal Title
  
  J.Immunol. 164
  
  Pages: 2565-2574
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer.2000
- Author(s)
  Kawano, K., Gomi, S., Tanaka, K., Tsuda, N., Kamura, T., Itoh, K., Yamada, A.
- Journal Title
  
  Cancer Res. 60
  
  Pages: 3550-3558
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Journal Article] A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma.2000
- Author(s)
  Nishizaka, S., Gomi, S., Harada, K., Oizumi, K., Itoh, K., Shichijo, S.
- Journal Title
  
  Cancer Res. 60
  
  Pages: 4830-4837
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 癌患者に対する免疫療法の治療効果および/または免疫療法後の予測方法、ならびに該方法に用いる遺伝子セットおよびキット2009
- Inventor(s)
  伊東恭悟、野口正典、山田亮、七條茂樹、小松誠和
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2009-230279
- Filing Date
  2009-10-02
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A3スーパータイプアレル陽性癌患者に対する癌ワクチン療法に有用なLCK由来ペプチド2008
- Inventor(s)
  伊東恭悟、野口正典
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2008-08-08
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] ctl誘導剤組成物2008
- Inventor(s)
  伊東恭悟、山田亮、七條茂樹
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2008-09-12
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24またはHLA-A2分子結合性EphB6変異体由来ペプチド2008
- Inventor(s)
  伊東恭悟、山中龍也、山田亮、七條茂樹
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2008-08-08
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] CTL誘導剤組成物2008
- Inventor(s)
  伊東恭悟、山田亮、七條茂樹
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2008-09-12
- Overseas
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24またはHLA-A2分子結合性EphB6変異体由来ペプチド2008
- Inventor(s)
  伊東恭悟、山中龍也、山田亮、七條茂樹
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2008-08-08
- Overseas
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] c型肝炎ウイルスによる肝癌の発症および再発予防ワクチン2008
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮, 由谷茂
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2008-276163
- Filing Date
  2008-10-27
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24分子結合性KIF由来ペプチド2007
- Inventor(s)
  伊東恭悟、原田守、山中龍也
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2007-08-03
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A3スーパータイプの患者に対するがんワクチンのためのLck-由来ペプチドの同定2007
- Inventor(s)
  伊東恭悟, 野口正典, 原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2007-212179
- Filing Date
  2007-08-16
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Patent] c型肝炎ウイルス2a由来HLA-A2拘束性抗原ペプチド2007
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2007-01-23
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A3スーパータイプアレル陽性癌患者に対する癌ワクチン療法に有用なLck由来ペプチド2007
- Inventor(s)
  伊東恭悟、野口正典、原田守
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2007-212179
- Filing Date
  2007-08-16
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A3スーパータイプアレル陽性前立腺癌患者に対する癌ワクチン療法に有用なSART3由来ペプチド2007
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Filing Date
  2007-07-11
- Description
  「研究成果報告書概要(和文)」より
- Overseas
- Data Source
  KAKENHI-PROJECT-18310147
[Patent] 複数タイプのHLAに結合性のペプチドからなるがんワクチン製剤2007
- Inventor(s)
  伊東恭悟、七條茂樹、山田亮
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2007-241161
- Filing Date
  2007-09-18
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A3スーパータイプァレル陽性前立腺癌患者に対する癌ワクチン療法に有用なSART3由来ペプチド2007
- Inventor(s)
  伊東恭悟、原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Filing Date
  2007-07-11
- Overseas
- Data Source
  KAKENHI-PROJECT-18310147
[Patent] c型肝炎ウイルス由来ペプチド2007
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮, 由谷茂
- Industrial Property Rights Holder
  (株)グリーンペプタイド
- Filing Date
  2007-01-23
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A3スーパータイプの患者に対するがんワクチンのためのLck-由来ペプチドの同定2007
- Inventor(s)
  伊東恭悟、野口正典、原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2007-212179
- Filing Date
  2007-08-16
- Data Source
  KAKENHI-PROJECT-18310147
[Patent] HLA-A24分子結合性KIF由来ペプチド2007
- Inventor(s)
  伊東恭悟、原田守、山中龍也
- Filing Date
  2007-08-03
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A3スーパータイプアレル陽性前立腺癌患者に対する癌ワクチン療法に有用なSART3由来ペプチド2007
- Inventor(s)
  伊東恭悟、原田守
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2007-07-11
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24またはHLA-A2分子結合性EphB6変異体由来ペプチド2007
- Inventor(s)
  山田亮、伊東恭悟、七條茂樹、山中龍也
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2007-217888
- Filing Date
  2007-08-24
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24分子結合性扁平上皮癌抗原由来ペプチド2006
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Filing Date
  2006-07-27
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A3スーパータイプアレル陽性前立腺癌患者に対する癌ワクチン療法に有用なSART3由来ペプチド2006
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2006-190276
- Filing Date
  2006-07-11
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24分子結合性扁平上皮癌抗原由来ペプチド2006
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2006-07-27
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A3スーパータイプアレル分子陽性前立腺癌患者に対する癌ワクチン候補となる前立腺関連蛋白由来ペプチド2006
- Inventor(s)
  伊藤恭悟, 原田守, 野口正典
- Industrial Property Rights Holder
  学校法人久留米大学
- Filing Date
  2006-06-22
- Data Source
  KAKENHI-PROJECT-18310147
[Patent] c型肝炎ウイルス由来ペプチド2006
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮, 由谷茂
- Industrial Property Number
  2006-220542
- Filing Date
  2006-08-11
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24分子結合性副甲状腺ホルモン関連蛋白由来ペプチドを含有する医薬組成物2006
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Filing Date
  2006-07-20
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24分子結合性扁平上皮癌抗原由来ペプチド2006
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2006-07-27
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24分子結合性扁平上皮癌抗原由来ペプチド2006
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2006-07-27
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24分子結合性副甲状腺ホルモン関連蛋白由来ペプチドを含有する医薬組成物2006
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2006-07-20
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] 医用診断処理装置2006
- Inventor(s)
  伊東恭悟, 七條茂樹, 室谷健太, 小松誠和, 柳川堯
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2006-08-30
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] c型肝炎ウイルス感染に関連する肝疾患の予後の予測2006
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮, 小松誠和, 由谷茂
- Industrial Property Rights Holder
  (株)グリーンペプタイド
- Filing Date
  2006-04-19
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] c型肝炎ウイルス感染に関連する肝疾患の予後の予測2006
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮, 小松誠和, 由谷茂
- Industrial Property Rights Holder
  (株)グリーンペプタイド
- Filing Date
  2006-04-19
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24分子結合性扁平上皮癌抗原由来ペプチド2006
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2007-529482
- Filing Date
  2006-07-27
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24分子結合性KIF由来ペプチド2006
- Inventor(s)
  伊東恭悟, 原田守, 山中龍也
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2006-213398
- Filing Date
  2006-08-04
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] c型肝炎ウイルス由来ペプチド2006
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮, 由谷茂
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2006-08-10
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] c型肝炎ウイルス由来ペプチド2006
- Inventor(s)
  伊東恭悟, 佐田通夫, 山田亮, 由谷茂
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2006-08-29
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] スギ花粉症の診断方法2006
- Inventor(s)
  伊東恭悟, 原田守, 小松誠和, ほか1名
- Industrial Property Rights Holder
  (株)クリーンペプタイド
- Industrial Property Number
  2006-288853
- Filing Date
  2006-10-24
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24分子結合性KIF由来ペプチド2006
- Inventor(s)
  伊東恭悟, 原田守, 山中龍也
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2006-213398
- Filing Date
  2006-08-04
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] がん患者の予後予測方法2006
- Inventor(s)
  伊東恭悟, 七條茂樹, 小松誠和, 唐宇飛, 野口正典, ほか2名
- Industrial Property Rights Holder
  (株)グリーンペプタイド
- Industrial Property Number
  2006-151504
- Filing Date
  2006-05-31
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] Combination Therapy of Peptide Vaccination and Estramustine Treatment2006
- Inventor(s)
  伊東恭悟, 野口正典
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2006-04-28
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A3スーパータイプアレル陽性前立腺癌患者に対する癌ワクチン療法に有用なSART3由来ペプチド2006
- Inventor(s)
  伊藤恭悟, 原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2006-190276
- Filing Date
  2006-07-11
- Data Source
  KAKENHI-PROJECT-18310147
[Patent] 医用診断処理装置2006
- Inventor(s)
  伊東恭悟, 七條茂樹, 室谷健太, 小松誠和, 柳川堯
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2007-533299
- Filing Date
  2006-08-30
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A3スーパータイプアレル分子陽性前立腺癌患者に対する癌ワクチン候補となる前立腺関連蛋白由来ペプチド2006
- Inventor(s)
  伊東恭悟, 原田守, 野口正典
- Industrial Property Rights Holder
  (株)グリーンペプタイド
- Filing Date
  2006-06-22
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24分子結合性副甲状腺ホルモン関連蛋白由来ペプチドを含有する医薬組成物2005
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2005-221399
- Filing Date
  2005-07-29
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] 前立腺関連抗原由来HLA-A2結合性ペプチド2005
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2005-06-15
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24分子結合性扁平上皮癌抗原由来ペプチド2005
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2005-230657
- Filing Date
  2005-08-09
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A24拘束性腫瘍抗原ペプチド2005
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  久留米大学
- Filing Date
  2005-11-24
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] HLA-A3スーパータイプアレル分子陽性前立腺癌患者に対する癌ワクチン候補となる前立腺関連蛋白由来ペプチド2005
- Inventor(s)
  伊東恭悟, 原田守, 野口正典
- Industrial Property Rights Holder
  久留米大学
- Industrial Property Number
  2005-190105
- Filing Date
  2005-06-29
- Data Source
  KAKENHI-PROJECT-17016074
[Patent] 前立腺関連抗原由来HLA-A24結合ペプチド2004
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2004-179311
- Filing Date
  2004-06-17
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] ストレス誘導抗アポトーシス分子(IEX-1)由来ペプチド2004
- Inventor(s)
  伊東恭悟
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2004-026691
- Filing Date
  2004-02-03
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] ストレス誘導抗アポトーシス分子(IEX-1)由来ペプチド2004
- Inventor(s)
  伊東恭悟
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2004-026691
- Filing Date
  2004-02-03
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 上皮細胞増殖因子受容体(EGFR)由来ペプチド2004
- Inventor(s)
  伊東恭悟, 七條茂樹
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2004-015676
- Filing Date
  2004-01-23
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 前立腺関連抗原由来HLA-A24結合ペプチド2004
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2004-179311
- Filing Date
  2004-06-17
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 上皮細胞増殖因子受容体(EGFR)由来ペプチド2004
- Inventor(s)
  伊東恭悟, 七條茂樹
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2004-015676
- Filing Date
  2004-01-23
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 副甲状腺ホルモン関連タンパク質のHLA-A24または-A2結合ペプチド2003
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2003-408891
- Filing Date
  2003
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] Zesteホモログ2のエンハンサーのHLA-A24結合ペプチド2003
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2003-408895
- Filing Date
  2003-12-08
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] CD4 陽性 T 細胞に認識されるペプチド2003
- Inventor(s)
  伊東恭悟, 原田守
- Industrial Property Rights Holder
  伊東恭悟
- Industrial Property Number
  2003-404911
- Filing Date
  2003-12-03
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] HER2/neu由来ペプチドおよびその治療上の用途2003
- Inventor(s)
  伊東恭悟, 七條茂樹
- Industrial Property Rights Holder
  学校法人久留米大学
- Industrial Property Number
  2003-275465
- Filing Date
  2003
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 腫瘍抗原2002
- Inventor(s)
  伊東恭悟, 山田亮
- Industrial Property Rights Holder
  伊東恭悟
- Industrial Property Number
  2002-286676
- Filing Date
  2002
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 腫瘍抗原2002
- Inventor(s)
  伊東恭悟, 七條茂樹
- Industrial Property Rights Holder
  伊東恭悟
- Industrial Property Number
  2002-126764
- Filing Date
  2002
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 腫瘍抗原2001
- Inventor(s)
  伊東恭悟
- Industrial Property Rights Holder
  伊東恭悟
- Industrial Property Number
  2001-376415
- Filing Date
  2001
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 腫瘍抗原2001
- Inventor(s)
  伊東恭悟, 七條茂樹
- Industrial Property Rights Holder
  伊東恭悟
- Industrial Property Number
  2001-191974
- Filing Date
  2001
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 腫瘍抗原2001
- Inventor(s)
  伊東恭悟, 七條茂樹
- Industrial Property Rights Holder
  伊東恭悟
- Industrial Property Number
  2001-177058
- Filing Date
  2001
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 腫瘍抗原2001
- Inventor(s)
  伊東恭悟, 七條茂樹
- Industrial Property Rights Holder
  伊東恭悟
- Industrial Property Number
  2001-333219
- Filing Date
  2001
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 腫瘍抗原2000
- Inventor(s)
  伊東恭悟, 山田亮
- Industrial Property Rights Holder
  伊東恭悟
- Industrial Property Number
  2000-304155
- Filing Date
  2000
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Patent] 腫瘍抗原2000
- Inventor(s)
  伊東恭悟
- Industrial Property Rights Holder
  伊東恭悟
- Industrial Property Number
  2000-231814
- Filing Date
  2000
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-12213134
[Presentation] Phase I/II study to evaluate the efficacy of TAS0313, the cancer peptide vaccine, in combination with pembrolizumab in locally advanced or metastatic urothelial carcinoma.2021
- Author(s)
  Ryuji Matsumoto, Junji Yonese, Takahiro Kojima, Hideaki Miyake, Nobuaki Matsubara, Hiroji Uemura, Masatoshi Eto, Naokazu Ibuki, Wataru Obara, Akito Terai, Satoshi Fukasawa, Shigetaka Suekane, Hiroyuki Nishiyama
- Organizer
  ASCO Annual Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K09182
[Presentation] 尿路上皮がん患者に対する個別化がんぺプチドワクチン療法のバイオマーカー2020
- Author(s)
  末金茂高、西原聖顕、植田浩介、由谷茂、七條茂樹、野口正典、伊東恭悟、井川掌
- Organizer
  第108回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-18K09182
[Presentation] 尿路上皮がん患者に対する個別化がんペプチドワクチンの再発予防効果2019
- Author(s)
  末金　茂高、植田　浩介、西原　聖顕、野口　正典、伊東　恭悟、井川　掌
- Organizer
  第107回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-18K09182
[Presentation] 尿路上皮がん再発予防がんペプチドワクチンの免疫誘導能2019
- Author(s)
  末金　茂高、野口　正典、西原　聖顕、植田　浩介、由谷　茂、伊東　恭悟、井川　掌
- Organizer
  第40回癌免疫外科研究会
- Invited
- Data Source
  KAKENHI-PROJECT-18K09182
[Presentation] Feasibility of Personalized Peptide Vaccination for Urothelial Cancer Patients Without Distant Metastasis as a Preventive Cancer Vaccine2019
- Author(s)
  Suekane S,Ueda K,Nishihara K,Noguchi M,Yutani S,Shichijo S,Itoh K,Igawa T
- Organizer
  SIU　2019国際泌尿器科学会議
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K09182
[Presentation] 乳癌におけるペプチドワクチン療法の臨床開発-The Development of Therapeutic Peptide Vaccines for Metastatic Recurrent Breast Cancer-2016
- Author(s)
  唐　宇飛、岩熊伸高、岡部実奈、朔　周子、赤木由人、山田　亮、七條茂樹、伊東恭悟
- Organizer
  第29回日本バイオセラピィ学会学術集会総会
- Place of Presentation
  久留米
- Year and Date
  2016-12-01
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] Clinical evaluation of detecting circulating tumor cells (CTC) in metastatic breast cancer2016
- Author(s)
  Mina OKABE,Uhi Toh,Nobutaka Iwakuma,Shuko Saku,Yuko Kimitsuki,Mai Mishima,Shigeki Shichijo,Kyogo Itoh,Yoshito Akagi
- Organizer
  The 14th Asian Breast Diseases Association Meeting & Symposium
- Place of Presentation
  Fukuoka
- Year and Date
  2016-09-02
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] 乳癌におけるペプチドワクチン療法後の抗前立腺関連抗原(prostate-related antigen)血清抗体価の臨床的意義2016
- Author(s)
  唐　宇飛、岡部実奈、岩熊伸高、三島麻衣、山田　亮、七條茂樹、伊東恭悟、笹田哲朗、赤木由人
- Organizer
  第116回日本外科学会定期学術集会
- Place of Presentation
  大阪
- Year and Date
  2016-04-14
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] Real-time indocyanine green (ICG) fluorescence imaging technique for the detection of SLNs in early-stage breast cancer2016
- Author(s)
  Shuko SAKU,Uhi Toh,Nobutaka Iwakuma,Mai Mishima,Mina Okabe,Yuko Kimitsuki,Momoko Akashi,Yoshito Akagi
- Organizer
  The 14th Asian Breast Diseases Association Meeting & Symposium
- Place of Presentation
  Fukuoka
- Year and Date
  2016-09-02
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] Correlation between HER2 related biomarkers (HER2, p95HER2, HER3, PTEN and PIK3CA) and treatment outcome of lapatinib plus capecitabine in HER2-positive metastatic breast cancer refractory to trastuzumab2016
- Author(s)
  Reiki Nishimura, Uhi Toh, Maki Tanaka, Michiyo Saimura, Yasuhiro Okumura, Tsuyoshi Saito, Toshihiro Tanaka, Megumi Teraoka, Kazuo Shimada, Kazuhisa Katayama, Toshihiro Koga, Kaname Kurashita, Satoshi Hasegawa, Hidekazu Todoroki, Hiroaki Ueo, Nobuyuki Arima, Shoshu Mitsuyama, Kazuo Tamura
- Organizer
  2016 ASCO Annual Meeting
- Place of Presentation
  シカゴ
- Year and Date
  2016-06-03
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] The clinical development of therapeutic peptide vaccines for breast cancer treatmemt2016
- Author(s)
  Uhi Toh,,Nobutaka Iwakuma,Mina Okabe,Shuko Saku,Momoko Akashi,Shigeki Shichijo,Kyogo Itoh,Akira Yamada,Yoshito Akagi
- Organizer
  The 14th Asian Breast Diseases Association Meeting & Symposium
- Place of Presentation
  Fukuoka
- Year and Date
  2016-09-02
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] 治療抵抗性トリプルネガティブ乳癌に対して19種混合ペプチドワクチン（KRM-19)が著効した1例2016
- Author(s)
  朔　周子、唐　宇飛、岩熊伸高、岡部実奈、山田　亮、七條茂樹、伊東恭悟、赤木由人
- Organizer
  第29回日本バイオセラピィ学会学術集会総会
- Place of Presentation
  久留米
- Year and Date
  2016-12-01
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] Effects of derivative vitamin D3 in colorectal cancer2016
- Author(s)
  Teruo Sasatomi, Uhi Toh, Yutaka Ogata, Yoshito Akagi
- Organizer
  2016 ASCO Annual Meeting
- Place of Presentation
  シカゴ
- Year and Date
  2016-06-03
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] トリプルネガティブ乳癌に対する混合ペプチドワクチン（KRM-19)の早期第2相臨床試験2016
- Author(s)
  朔　周子、唐　宇飛、岩熊伸高、三島麻衣、岡部実奈、君付優子、赤木由人、七條茂樹、山田　亮、伊東恭悟
- Organizer
  第24回日本乳癌学会学術集会
- Place of Presentation
  東京
- Year and Date
  2016-06-16
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] The potential of nanotechnology for breast cancer imaging2016
- Author(s)
  Nobutaka IWAKUMA,Stephen R Grobmyer,Uhi Toh,Mina Okabe,Shuko Saku,Momoko Akashi,Yoshito Akagi
- Organizer
  The 14th Asian Breast Diseases Association Meeting & Symposium
- Place of Presentation
  Fukuoka
- Year and Date
  2016-09-02
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] 血清抗前立腺関連抗原(prostate-related antigen)抗体価の乳癌ペプチドワクチン療法における臨床的意義に関する検討2016
- Author(s)
  唐　宇飛、岩熊伸高、岡部実奈、朔　周子、赤司桃子、赤木由人、山田　亮、七條茂樹、伊東恭悟
- Organizer
  第75回日本癌学会学術集会
- Place of Presentation
  横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] 標準治療抵抗性及び早期乳癌に対するペプチドワクチン療法後の免疫学的反応性に関する検討2015
- Author(s)
  唐　宇飛、古川実奈、岩熊伸高、三島麻衣、笹田哲朗、松枝智子、伊東恭悟、赤木由人
- Organizer
  第115回日本外科学会定期学術集会
- Place of Presentation
  名古屋
- Year and Date
  2015-04-16
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] 転移再発トリプルネガティブ乳癌に対するテーラメイド癌ペプチドワクチン療法第Ⅱ相試験2015
- Author(s)
  高橋龍司、唐　宇飛、岩熊伸高、中川志乃、松枝智子、山田　亮、伊東恭悟、赤木由人、笹田哲朗
- Organizer
  第115回日本外科学会定期学術集会
- Place of Presentation
  名古屋
- Year and Date
  2015-04-16
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] CTL AND IGG RESPONSE TO TUMOR-ASSOCIATED ANTIGENS AS PREDICTIVE FACTORS OF THEREPEUTIC PEPTIDE VACCINATION FOR PATIENTS WITH METASTATIC RECURRENT BREAST CANCER2015
- Author(s)
  Uhi Toh,Mina Okabe,Nobutaka Iwakuma,Mai Mishima,Shigeki Shichijo,Akira Yamada,Kyogo Itoh,Yoshito Akagi
- Organizer
  Advanced Breast Cancer/Third International Consensus Conference
- Place of Presentation
  Portugal,リスボン
- Year and Date
  2015-11-05
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] 乳癌局所の免疫環境におけるPD-1/PD-L1抗原発現とその臨床的意義に関する検討2015
- Author(s)
  岡部実奈、唐　宇飛、岩熊伸高、三島麻衣、竹中美貴、関　直子、河原明彦、鹿毛政義、森田　道、山口　倫、伊東恭悟、赤木由人
- Organizer
  第５３回日本癌治療学会学術集会
- Place of Presentation
  京都
- Year and Date
  2015-10-29
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] Local immunologic environment related with tumor infiltrating lymphocytes (TIL) and PD-1/PD-L1 expression in early stage breast cancer2015
- Author(s)
  Okabe M, Toh U, Iwakuma N, Mishima M, Kawahara A, Kage M, Itoh K, Akagi Y.
- Organizer
  SanAntonio Breast Cancer Symposium 2015
- Place of Presentation
  USA, SanAntonio
- Year and Date
  2015-12-08
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] Serum IgG response against prostate-related antigen revealed by personalized peptide vaccination in patients with metastatic recurrent breast cancer Local immunologic environment related with tumor infiltrating lymphocytes (TIL) and PD-1/PD-L1 expression in early stage breast cancer2015
- Author(s)
  Toh U, Okabe M, Iwakuma N, Mishima M, Shichijo S, Yamada A, Noguchi M, Itoh K, Akagi Y.
- Organizer
  SanAntonio Breast Cancer Symposium 2015
- Place of Presentation
  USA, SanAntonio
- Year and Date
  2015-12-08
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] １９種ペプチドワクチン（KRM-19)によるトリプルネガティブ乳癌の早期第2相試験2015
- Author(s)
  唐　宇飛、岡部実奈、岩熊伸高、三島麻衣、山田　亮、七條茂樹、伊東恭悟、赤木由人
- Organizer
  第５３回日本癌治療学会学術集会
- Place of Presentation
  京都
- Year and Date
  2015-10-29
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] トリプルネガティブ乳癌に対する免疫学的治療の試み2015
- Author(s)
  唐宇飛、岡部（古川）実奈、岩熊伸高、三島麻衣、竹中美貴、高橋龍司、中川志乃、河原明彦、鹿毛政義、伊東恭悟、赤木由人
- Organizer
  第23回日本乳癌学会学術集会
- Place of Presentation
  東京
- Year and Date
  2015-07-02
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] がんペプチドワクチン:迅速な実用化へ向けて2009
- Author(s)
  伊東恭悟, 野口正典, 山田亮, 七條茂樹, 由谷茂, 小松誠和, 山中龍也, 柳本泰明, 松本和将
- Organizer
  第22回日本バイオセラピー学会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] 細胞を用いたがんワクチンの課題と展望2009
- Author(s)
  伊東恭悟, 小松誠和, 野口正典
- Organizer
  第68回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] HLA-24A陽性進行癌を対象としたテーラーメイド型ペプチドワクチン療法の第I相試験および継続投与試験2008
- Author(s)
  寺崎瑞彦, 野口正典, 伊東恭悟, 内藤誠二, 植村天受, 赤座英之, 渋井壮一郎, 藤巻高光, 青木友和, 峯田寿裕, 梶原浩司
- Organizer
  第46回日本癌治療学会総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] Capability of SART3-109 peptide to induce cytotoxic T-Lymphocytes from prostate cancer patients with HLA-All,-A31, or-A33 alleles2008
- Author(s)
  小松誠和、伊東恭悟, 他
- Organizer
  第12回基盤的癌免疫研究会総会
- Place of Presentation
  埼玉
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] Capability of SART3-109 peptide to induce cytotoxic T-Lymphocytes from prostate cancer patients with HLA-A11, -A31, or -A33 alleles2008
- Author(s)
  小松誠和, Elnisr Rashed Mohamed, 内藤雅康, 寺崎康展, Niu Yamei, 七條茂樹, 伊東恭悟, 野口正典
- Organizer
  第12回基盤的癌免疫研究会総会
- Place of Presentation
  埼玉
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] Survival benefit of personalized peptide vaccine for advanced cancer patients : Up date of enrolled 476 cases.(テーラーメイド癌ペプチドワクチン臨床試験の生存解析 : 475症例でのアップデート)2008
- Author(s)
  峯孝志、伊東恭悟, 他
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] Survival benefit of personalized peptide vaccine for advanced cancer patients: Up date of enrolled 475 cases2008
- Author(s)
  峯孝志, 野口正典, 藤堂省, 柳本泰明, 植村天受, 山中龍也, 嘉村敏治, 岡正朗, 奥野清隆, 松本和将, 山田亮, 伊東恭悟
- Organizer
  第67回日本癌学会学術総会
- Place of Presentation
  名古屋
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] テーラーメイドがんペプチドワクチンの免疫および臨床効果。(Immunological and clinical effects of personalized peptide vaccine for advanced cancer)2008
- Author(s)
  Yamada Akira, Itoh Kyogo
- Organizer
  第38回日本免疫学会総会・学術集会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] テーラーメイドがんペプチドワクチンの免疫および臨床効果2008
- Author(s)
  Yamada Akira, Itoh Kyogo
- Organizer
  第38回日本免疫学会総会・学術集会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] Identification of apeptide derived ffom HCV inducing cellular responses with various HLA clalss I-A alleles2007
- Author(s)
  Shichljo S, Itoh K, et. al.
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-18310147
[Presentation] Personalized peptide vaccination for cancer patient.2007
- Author(s)
  Itoh K, Noguti M, Yamanaka R, Yamada A, Shichijo S
- Organizer
  The 27th General Assembly of the Japan Medical Congress.
- Place of Presentation
  Osaka
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Presentation] Elimination of cancer stem cells in drug-resistance by Notch and Numb-peptide activated T cells.2007
- Author(s)
  Mine T, Itoh K, et. al.
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] Identification of EphB6 variant-derived epitope peptides recognized by cytotoxic T lymphocytes.,2007
- Author(s)
  Jin M, Itoh K, et. al.
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] Identification of a peptide derived from HCV inducing cellular responses with various HLA class I-A alleles.2007
- Author(s)
  Shichijo S, Itoh K, et. al.
- Organizer
  第66回目本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] テーラーメイド癌ペプチドワクチン開発の現状と展望2007
- Author(s)
  伊東恭悟他
- Organizer
  第27回日本医学会総会
- Place of Presentation
  大阪
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] Symposium 「Promotion of drug development in oncology throughinternational cooperation」2007
- Author(s)
  Toyoshima S, Itoh K
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] Identification of a peptide derived from HCV inducing cellular responses with various HLA class I -A alleles.2007
- Author(s)
  Shichijo S, Komohara Y, Matsueda S, Yutani S, Komatsu N, Sata M, Yamada A, Itoh K
- Organizer
  The 66th Annual Meeting of the Japanese Cancer Association.
- Place of Presentation
  Yokohama
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Presentation] テーラーメイド癌ペプチドワクチン開発の現状と展望2007
- Author(s)
  伊東恭悟, 他4名
- Organizer
  第27回日本医学会総会
- Place of Presentation
  大阪
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Presentation] Identification of a peptide derived from HCV inducing cellular responses with various HLA class I-A alleles2007
- Author(s)
  Shichijo S, Itoh K, et. al.
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-18310147
[Presentation] Phase I clinical trial of pan-HLA type personalized peptide vaccine for advanced cancer patients.2007
- Author(s)
  Yamada A, Itoh K, et. al.
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-17016074
[Presentation] The New Color Charge Coupled Device Camera System (HyperEye Medical System)for Intraoperative Detection of Sentinel Lymph Node from Breast Cancer
- Author(s)
  Uhi Toh,Nobutaka Iwakuma,Mai Mishima,Miki Takenaka,Mina Furukawa,Yoshito Akagi,Maki Tanaka
- Organizer
  3rd International Breast Cancer Symposium
- Place of Presentation
  Jeiju, Korea
- Year and Date
  2014-04-24 – 2014-04-26
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] 乳癌の免疫腫瘍抗原を治療ターゲットとしたトランスレーションリサーチ－基礎実験から臨床研究へ－
- Author(s)
  唐　宇飛、関　直子、竹中美貴、高橋龍司、岩熊伸高、三島麻衣、藤井輝彦、笹田哲朗、伊東恭悟、白水和雄
- Organizer
  第22回日本乳癌学会学術集会
- Place of Presentation
  大阪
- Year and Date
  2014-07-10 – 2014-07-12
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] Safety and immunologic efficacy of personalized multiple HLA class I-restricted peptide vaccines for berast cancer patients in the adjuvant setting.
- Author(s)
  U.Toh,N.Iwakuma,M.Mishima,M.Takenaka,R.Takahashi,M.Furukawa,T.Fujii,E.Ogo,S.Nakagawa,M.Tanaka,T.Sasada,K.Itoh,Y.Akagi
- Organizer
  2014 ASCO Annual Meeting
- Place of Presentation
  Chicago, USA
- Year and Date
  2014-05-30 – 2014-06-03
- Data Source
  KAKENHI-PROJECT-26461965
[Presentation] 転移再発乳癌に対するテーラーメイド癌ペプチドワクチン療法　第Ⅱ相試験
- Author(s)
  高橋龍司、唐　宇飛、白水和雄、松枝智子、伊東恭悟、笹田哲朗
- Organizer
  第114回日本外科学会定期学術集会
- Place of Presentation
  京都
- Year and Date
  2014-04-03 – 2014-04-05
- Data Source
  KAKENHI-PROJECT-26461965

1. SHICHIJO Shigeki (30080592)

# of Collaborated Projects: 9 results

# of Collaborated Products: 19 results
2. YAMADA Akira (50158177)

# of Collaborated Projects: 5 results

# of Collaborated Products: 26 results
3. IMAI Yasuhisa (90268847)

# of Collaborated Projects: 5 results

# of Collaborated Products: 0 results
4. NAKAO Masanobu (40258447)

# of Collaborated Projects: 5 results

# of Collaborated Products: 0 results
5. YAMANA Hideaki (30140669)

# of Collaborated Projects: 4 results

# of Collaborated Products: 0 results
6. 益子高 (30157200)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
7. HAYASHI Akihiro (70180958)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
8. SASATOMI Teruo (20196190)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
9. ENDO Keigo (10115800)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
10. NAKAMURA Yusuke (70217909)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
11. GOMI Shinnya (30289368)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
12. MORI Osamu (20129597)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
13. NOGUCHI Masanori (10140691)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
14. Suekane Shigetaka (40235833)

# of Collaborated Projects: 2 results

# of Collaborated Products: 10 results
15. MORIYA Fukuko (80449917)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
16. 菊地浩吉 (00045345)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
17. 松浦晃洋 (70157238)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
18. 笠原正典 (30241318)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
19. 星野友昭 (00261066)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
20. UEDA Ryuzo (20142169)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
21. MIYAZONO Kohei (90209908)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
22. SAITO Izumu (70158913)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
23. IMAI Kohzoh (60117603)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
24. HASHIDA Mitsuru (20135594)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
25. INAZAWA Johji (30193551)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
26. MUTO Tetsuichiro (20110695)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
27. TSURUO Takashi (00012667)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
28. FUJIWARA Ryoichi (20209133)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
29. OGATA Yutaka (20177124)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
30. SAITSU Hideki (60186921)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
31. TOH Yuji (50197836)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
32. ISOMOTO Hiroharu (80080745)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
33. SASAZUKI Takehiko (50014121)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
34. ISHIKAWA Fuyuki (30184493)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
35. NODA Tetsuo (10183550)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
36. KAMATAKI Tetsuya (00009177)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
37. NIWA Otsura (80093293)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
38. NAKAMA Takekuni (50221453)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
39. KUSUHARA Masahiro (40195441)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
40. MORI Osamu (10175630)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
41. YAGITA Hideo (30182306)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
42. SHIROUZU Kazuo md (20216203)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
43. YUTANI Shigeru (20279160)

# of Collaborated Projects: 1 results

# of Collaborated Products: 8 results
44. SAKAMOTO Kikuo (70279222)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
45. Toh Uhi (60268901)

# of Collaborated Projects: 1 results

# of Collaborated Products: 32 results
46. 神奈木玲児 (80161389)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
47. 別宮好文 (70199454)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
48. 高橋利忠 (00124529)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
49. 西村孝司 (30143001)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
50. 日野田裕治 (10165128)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
51. 片岡明夫 (40194758)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
52. 目加田英輔 (20135742)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
53. 山田源 (80174712)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
54. 井川掌 (40295069)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
55. 植田浩介 (60569440)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
56. 西原聖顕 (90389297)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
57. YAMADA Satoko

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
58. 関直子

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
59. 笹田哲朗

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

ITOH Kyogo 伊東 恭悟

伊東 恭悟 イトウ キヨウゴ

伊藤 恭悟 イトウ キョウゴ

Research Projects

Research Products

Co-Researchers

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Study of molecular basis for T cell-mediated recognition of antigens in subjects with HLA-A3 super typePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Basic research of peptide vaccine as therapeutic cancer vaccinePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Study of tumor associated antigens recognized by human CD8^+ cytotoxic T lymphocytesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Institution

Identification of genes encoding tumor-rejection antigens of cancers from digestive tract and development of cancer vaccinePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

ITOH Kyogo 伊東恭悟

伊東恭悟イトウキヨウゴ

伊藤恭悟イトウキョウゴ